Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

382.46 -1.60 (-0.42%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stryker declares an $0.84 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades'
Via Benzinga
Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers. 
Via StockStory
Earnings Scheduled For May 1, 2025
Via Benzinga
Demystifying Stryker: Insights From 5 Analyst Reviews
Via Benzinga
2 S&P 500 Stocks Worth Investigating and 1 to Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Exposures US Equities
Stryker’s (NYSE:SYK) Q1: Beats On Revenue
Medical technology company Stryker (NYSE:SYK) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per... 
Via StockStory
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Stryker reports first quarter 2025 operating results
From Stryker Corporation
Via GlobeNewswire
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year? 
Via Investor's Business Daily
Topics Animal Testing Economy Government
Exposures Animal Testing Economy Political
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Stryker (NYSE:SYK) will be reporting earnings tomorrow after market close. Here’s what investors should know. 
Via StockStory
Topics Economy World Trade
Exposures Economy Tariff
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference
From Stryker Corporation
Via GlobeNewswire
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know
Via Benzinga
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength. 
Via Benzinga
Topics ETFs
Top Analyst Reports For Bank Of America, Chevron & Stryker
Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation, Chevron Corporation, and Stryker Corporation, as well as two micro-cap stocks, Value... 
Via Talk Markets
Topics Stocks / Equities
Meritage Homes, TopBuild, Installed Building Products, Champion Homes, and Stryker Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
What Does the Market Think About Stryker?
Via Benzinga
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?
Although Stryker has dropped 5.3% to $335.22 per share over the past six months, it has beaten the S&P 500 by 8.6 percentage points. 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
Stryker to announce financial results for its first quarter of fiscal year 2025
From Stryker Corporation
Via GlobeNewswire
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. 
Via StockStory
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
From VB Spine, LLC
Via GlobeNewswire
Stryker completes sale of U.S. spinal implants business
From Stryker Corporation
Via GlobeNewswire
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
Exposures Political
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock
Via Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Stryker announces intention to nominate Manny Maceda to board of directors
From Stryker Corporation
Via GlobeNewswire
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.